bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.04.03.486896

Bidirectional modulation of neuronal excitability via ionic actuation of potassium

Abstract

Potassium K+ is a fundamental actor in the shaping of action potentials, and its concentration in the extracellular microenvironment represents a crucial modulator of neural excitability. Yet, its employment as a neuromodulation modality is still in its infancy. Recent advances in the technology of ionic actuators are enabling the control of ionic concentrations at the spatiotemporal scales of micrometers and milliseconds, thereby holding the promise of making the control of K+ concentration a key enabling technology for the next generation of neural interfaces. In this regard, a theoretical framework to understand the possibilities and limits offered by such technology is pivotal. To this aim, we exploit the Hodgkin-Huxley modeling framework, augmented to account for the perturbation of extracellular K+ concentration. We leverage methods of bifurcation analysis to investigate which regimes of electrical activity arise in the space of the input variables, namely the extent of ionic actuation and the synaptic current. We show that, depending on the type of target neuron, switchings of the class of excitability may occur in such space. These effects could rule out the possibility of eliciting tonic spiking when the extracellular K+ concentration is assumed as a sole control input. Building upon these findings, we show in simulations how to address the problem of neuromodulation via ionic actuation in a principled fashion. In this respect, we account for a bidirectional scenario, namely from the perspective of both inhibiting and stimulating electrical activity. We then provide a first-order motivation for the switchings of neural excitability in terms of the conductances of the K+-selective channels. Finally, we introduce a Pinsky-Rinzel-like model to investigate the effects of performing the ionic actuation locally at the neural membrane. Author summaryNeural interfaces rely on technologies to sense and perturb the electrical activity of neurons. For the latter aim, many strategies have been established to date, each one targeting a different actor involved in the electrophysiology of neurons. Examples include electrical, chemical, and optogenetic techniques. However, the main actors that shape neuronal signals, namely ions such as potassium K+, are still not directly targeted. Recent advances in bioelectronic technologies are enabling the manipulation of ionic concentrations as a viable strategy for neuromodulation, which we refer to as ionic actuation. These findings come mainly from the experimental literature, and the theoretical understanding of how ionic actuation can be used to shape neural activity is still lacking. This paper aims to help fill this gap, adopting the ionic actuation of K+ as a case study. Our results could guide the design and control of novel neural interfaces targeting the ionic composition of cellular fluids. Moreover, they may suggest novel therapies for pathologies related to impairments in the regulation of ionic homeostasis, such as drug-resistant epilepsy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Verardo, C., Jolivet, R., Mele, L. J., Giugliano, M., Palestri, P.. 2022-04-05. Bidirectional modulation of neuronal excitability via ionic actuation of potassium. https://doi.org/10.1101/2022.04.03.486896

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗